• AOD-9604 5mg

    37.99

    AOD-9604, lipolytic peptide fragment, which was derived from human growth hormone (HGH) during the late 1990s was modified from HGH residues 176-191. This modified compound primarily works as an element for fat burning and obesity treatment, while the exact mechanism by which this happens is still under research. It stimulates the breakdown (metabolism) of fat stores and inhibits the formation of fats without any detected side effects, affecting blood sugar levels or causing abnormal growth. In addition, the peptide shows several, apparently independent, positive effects on cartilage regeneration, improvement of metabolism or heart activity, confirmed by research.

  • CJC-1295 + DAC 5mg

    66.99

    CJC-1295+DAC is one of modified synthetic analogues of growth hormone releasing hormone (GHRH). It acts as a growth hormone (GH) secretagogue stimulating levels of GH and insulin-like growth factor 1 (IGF-1), while preserving GH pulsatility. This stimulation in turn is the basis for its effects confirmed in various studies in animals and humans. This peptide contains an additive called DAC – Drug Affinity Complex, which is added to the CJC-1295 molecule via a lysine linker, and provides protection during circulation in the bloodstream. The DAC enhances the pharmacokinetics of the peptide, and allows it to bind to the blood protein albumin, thereby extending the half-life of CJC-1295 relative to other similar analogue molecules and natural GHRH itself.

  • GHRP-2 5mg

    25.99

    Peptide GHRP-2, also known as pralmorelin, is a synthetic hexapeptide, one of the first growth hormone secretagogues, that is known for its muscle growth increasing, ghrelin stimulating, immune system strengthening or sleep improving properties shown in numerous researches. GHRP-2 activates the release of growth hormone (GH) by binding to the growth hormone secretagogue receptor. It is also an agonist of ghrelin, discovered gut hormone, which is able to stimulate GH secretion and appetite initiation.

  • Hexarelin 5mg

    29.99

    Hexarelin, also known as Examorelin, is a synthetic GH releasing hexapeptide, which activates growth hormone secretagogue receptor (GHSR) in the brain area. It is also ghrelin analog, similarly to other peptides such as GHRP-6. Beyond GH release and neuroendocrine effects, hexarelin might have also direct cardiovascular actions and cardioprotective effects. Compared with ghrelin, this peptide is chemically more stable and functionally more potent, therefore it could be potential future therapeutic medium. It can also improve fat measures and protect muscles.

  • Ipamorelin 5mg

    29.99

    Ipamorelin represents a synthetic pentapeptide derived from GHRP-1, which has a very potent growth hormone (GH) releasing properties with efficacy and potency comparable to GHRP-6, both in vitro and in vivo. Unlike other GH secretagogues, ipamorelin very surprisingly does not induce a significant increase in adrenocorticotropic hormone (ACTH) or cortisol levels. This selectivity is crucial, as many other GH secretagogues also stimulate the release of ACTH and cortisol, which can lead to unwanted side effects. It also increases bone mineral content, production of IGF-1 and insulin or muscle growth.

  • Mod GRF 1-29 (CJC-1295 no DAC) 5mg

    49.99

    Mod GRF 1-29 is a synthetic peptide identical to CJC-1295 without DAC compound. It is truncated analogue of growth hormone releasing hormone (GHRH), which was developed in 1980s from original GRF 1-29, but with purposefully prolonged half-life to ensure better therapeutical use. This modified version was shown to have similar or even the same effects as GHRH, including muscle and bone growth, wound healing, fat burning or positive effects on heart functions, metabolism or immune system.

  • MOTS-c 10mg

    Original price was: €65.00.Current price is: €42.99.

    MOTS-c is a small peptide derived from mitochondrial genome. During metabolic stress, it moves to the nucleus to regulate the expression of nuclear genes, promoting cellular balance. It is co-expressed in various tissues with mitochondria, and found in plasma, though its levels decline with age. MOTS-c, discovered by researchers at the University of Southern California around 2012, improves glucose metabolism in skeletal muscle, suggesting benefits for diabetes, obesity, and aging. This peptide is being studied for its potential in treating cardiovascular disease, insulin resistance, and inflammation. Studies also explore molecular mechanisms and therapeutic potentials, suggesting synthetic biology as a new approach for developing and applying MOTS-c.

  • Retatrutide 10mg

    Original price was: €200.00.Current price is: €139.99.

    Retatrutide (LY3437943) is an innovative investigational peptide developed by Eli Lilly that functions as a triple agonist of the GLP-1, GIP, and glucagon receptors—also referred to as a GGG triagonist. This combined receptor activation results in a synergistic effect on body weight reduction through increased energy expenditure, decreased food intake, delayed gastric emptying, and stimulation of lipolysis. Phase 2 clinical trials have demonstrated that retatrutide can reduce body weight by up to 24.2% over a 48-week period, while also improving cardiometabolic parameters such as blood pressure, lipid profile, and insulin sensitivity. Promising outcomes observed in both preclinical and clinical populations position retatrutide as one of the most promising candidates for the treatment of obesity and metabolic diseases, although further research remains necessary.